Literature DB >> 15990743

An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease.

Stefan K James1, Jonas Oldgren, Johan Lindbäck, Nina Johnston, Agneta Siegbahn, Lars Wallentin.   

Abstract

BACKGROUND: Inflammation plays an important role in unstable coronary artery disease (CAD). We assessed the kinetics of inflammatory markers from symptom onset in patients with unstable CAD and their relation to myocardial damage.
METHODS: Serial measurements of inflammatory mediators were performed in consecutive patients with unstable CAD enrolled at selected sites in the FRISC II (n = 558) and the GUSTO IV (n = 404) trials. The time from symptom onset was calculated for every serum sample (total 4400 samples).
RESULTS: Median levels of interleukin 6 and C-reactive protein reached their peaks at 36 to 42 hours and at 48 to 54 hours, respectively, from symptom onset and returned to early postsymptom levels within 6 weeks. The early increase occurred almost exclusively in patients with baseline troponin T elevation (>0.01 microg/L). In contrast, median levels of fibrinogen increased continuously up to 120 hours after symptom onset, independently of myocardial damage. At 6 months, fibrinogen levels were still higher than in the early phase after symptom onset. The median levels of interleukin 6, C-reactive protein, and fibrinogen were still higher at 6 months than in healthy controls matched for age and sex to a population with unstable CAD.
CONCLUSIONS: An early acute inflammatory reaction induced by myocardial damage seems to be superimposed on a chronic inflammatory condition, both of which might influence long-term outcome in unstable CAD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15990743     DOI: 10.1016/j.ahj.2004.08.026

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  12 in total

Review 1.  Impact of Atrial Fibrillation On Cardiovascular Mortality in the Setting of Myocardial Infarction.

Authors:  Mahmoud Suleiman; Doron Aranson
Journal:  J Atr Fibrillation       Date:  2012-12-16

Review 2.  Mechanisms of new-onset atrial fibrillation complicating acute coronary syndrome.

Authors:  J Wang; Y-M Yang; J Zhu
Journal:  Herz       Date:  2014-10-30       Impact factor: 1.443

Review 3.  Circulating microRNAs as novel biomarkers for the early diagnosis of acute coronary syndrome.

Authors:  J C Deddens; J M Colijn; M I F J Oerlemans; G Pasterkamp; S A Chamuleau; P A Doevendans; J P G Sluijter
Journal:  J Cardiovasc Transl Res       Date:  2013-07-30       Impact factor: 4.132

4.  Prognostic Role of High Sensitivity C-Reactive Protein in Patients With Acute Myocardial Infarction.

Authors:  Xiaoyuan Zhang; Shanjie Wang; Shaohong Fang; Bo Yu
Journal:  Front Cardiovasc Med       Date:  2021-05-24

5.  Opium addiction increases interleukin 1 receptor antagonist (IL-1Ra) in the coronary artery disease patients.

Authors:  Habibollah Saadat; Seyed Ali Ziai; Maryam Ghanemnia; Mohammad Hasan Namazi; Morteza Safi; Hosein Vakili; Ali Dabbagh; Omid Gholami
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

6.  Usefulness of C-reactive protein as a marker of early post-infarct left ventricular systolic dysfunction.

Authors:  Iwona Swiatkiewicz; Marek Kozinski; Przemyslaw Magielski; Joanna Gierach; Tomasz Fabiszak; Aldona Kubica; Adam Sukiennik; Eliano Pio Navarese; Grazyna Odrowaz-Sypniewska; Jacek Kubica
Journal:  Inflamm Res       Date:  2012-03-24       Impact factor: 4.575

7.  Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction.

Authors:  Yizhi Ren; Hao Zhu; Zhongguo Fan; Yali Gao; Nailiang Tian
Journal:  Exp Ther Med       Date:  2017-09-21       Impact factor: 2.447

8.  Lipoprotein-associated phospholipase A2 and oxidized low-density lipoprotein in young patients with acute coronary syndrome in China.

Authors:  Yuli Huang; Yu Wu; You Yang; Wensheng Li; Jianhua Lu; Yunzhao Hu
Journal:  Sci Rep       Date:  2017-11-23       Impact factor: 4.379

9.  Genome-Wide Association Study Identifies That the ABO Blood Group System Influences Interleukin-10 Levels and the Risk of Clinical Events in Patients with Acute Coronary Syndrome.

Authors:  Åsa Johansson; Jenny Alfredsson; Niclas Eriksson; Lars Wallentin; Agneta Siegbahn
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

10.  Plasma Macrophage Migration Inhibitor Factor Is Elevated in Response to Myocardial Ischemia.

Authors:  Fenling Fan; Lu Fang; Xiao-Lei Moore; Xuegang Xie; Xiao-Jun Du; David A White; Jessica O'Brien; Helen Thomson; Jun Wang; Hans G Schneider; Andris Ellims; Thomas W Barber; Anthony M Dart
Journal:  J Am Heart Assoc       Date:  2016-06-30       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.